APP and nonpapillary renal cell carcinoma: could correlate shorter cfDNA fragments of the gene amyloid beta (A4) precursor protein (APP) with prognostic factors for recurrence-free and OS in patients with ccRCC and the cfDNA integrity index calculated based on the ratio of these fragment concentrations showed a decreased trend from controls to mRCC patients (24).